These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


346 related items for PubMed ID: 7608428

  • 1. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
    Frishman WH, Pepine CJ, Weiss RJ, Baiker WM.
    J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
    [Abstract] [Full Text] [Related]

  • 2. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
    Frishman WH, Charlap S, Goldberger J, Kimmel B, Stroh J, Dorsa F, Allen L, Strom J.
    Am J Cardiol; 1985 Dec 06; 56(16):41H-46H. PubMed ID: 3934948
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J, Wang W, Skettino SL, Wolff AA, Combination Assessment of Ranolazine In Stable Angina (CARISA) Investigators.
    JAMA; 2004 Jan 21; 291(3):309-16. PubMed ID: 14734593
    [Abstract] [Full Text] [Related]

  • 10. Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.
    Frishman W, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J.
    Circulation; 1988 Apr 21; 77(4):774-86. PubMed ID: 3280158
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy of nifedipine gastrointestinal therapeutic system versus diltiazem when added to beta blockers in stable angina pectoris.
    Siu SC, Jacoby RM, Phillips RT, Nesto RW.
    Am J Cardiol; 1993 Apr 15; 71(11):887-92. PubMed ID: 8096670
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U, Zellner SR, Glasser S, Bittar N, Montoro R, Miller AB, Chaitman B, Schulman P, Stahl A, DiBianco R.
    Circulation; 1991 Dec 15; 84(6):2398-408. PubMed ID: 1959195
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute effects of nifedipine, diltiazem and their combination in patients with chronic stable angina: a double-blind, randomized, cross-over, placebo-controlled study.
    De Caprio L, Acanfora D, Odierna L, Di Palma A, Romaniello C, Rengo C, Giordano A, Rengo F.
    Eur Heart J; 1993 Mar 15; 14(3):416-20. PubMed ID: 8458364
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M, Tracz W, Kubler G, Negrusz-Kawecka M, Hlawaty M, Olszowska M, Salamon P.
    Przegl Lek; 1997 Mar 15; 54(5):324-8. PubMed ID: 9380807
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.